Myasthenia Gravis
Myasthenia gravis is an autoimmune neuromuscular disorder that causes weakness in the skeletal muscles. It occurs when antibodies block or destroy acetylcholine receptors at the junction between the nerve and muscle. Symptoms include drooping eyelids, double vision, difficulty swallowing, and muscle fatigue that worsens with activity.
You may qualify for clinical trials that provide Vyvgart at no cost
Clinical trials may give you access to this treatment while helping advance medical research
Search TrialsInsurers typically require trial and failure of pyridostigmine (Mestinon) and at least one immunosuppressant (mycophenolate, azathioprine, or prednisone) before approving biologics like Vyvgart or complement inhibitors like Soliris/Ultomiris. IVIG is often restricted to acute exacerbations or pre-surgical optimization rather than ongoing maintenance therapy.
Must fail pyridostigmine and immunosuppressants before biologic therapy
Very Common
AChR or MuSK antibody testing not documented
Common
IVIG limited to acute exacerbation — not approved for maintenance
Common
Vyvgart or complement inhibitor denied without prior biologic failure
Occasional
Insufficient documentation of disease severity (MG-ADL or QMG scores)
Occasional
- 1.Document AChR or MuSK antibody status — antibody-positive status strengthens the case
- 2.Include MG-ADL and/or QMG scores showing disease severity
- 3.Document all prior immunosuppressant trials with dates, doses, and reasons for failure
- 4.For complement inhibitor requests, document generalized MG with inadequate response to standard therapy
- 5.Cite MGFA classification and note any myasthenic crisis history
Active clinical trials that may provide treatment at no cost.
Copay cards, patient assistance programs, and foundation grants for this condition's treatments.
Want to know what you'll actually pay?
Estimate your annual out-of-pocket cost with and without assistance programs.
Estimate My CostsDenied for Myasthenia Gravis Treatment?
Ellen can decode your denial, find your appeal strategy, and generate your appeal letter — free.